New Key Statistics Module, Z-Score and F-Score
TSXV:AVCR Key Ratios
Market Cap C$ M | 15.94 |
Enterprise Value C$ M | 15.70 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 7.27 |
Price/Sales | 3.90 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) C$ M | 3.00 |
EPS (TTM) C$ | -0.004 |
Beneish M-Score | 0 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | 47.00 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -45.63 |
EV-to-EBITDA | 146.70 |
PEG | -- |
Shares Outstanding M | 99.64 |
Net Margin (%) | -8.55 |
Operating Margin % | -8.29 |
Pre-tax Margin (%) | -8.55 |
Quick Ratio | 1.82 |
Current Ratio | 1.84 |
ROA % (ttm) | -13.69 |
ROE % (ttm) | -17.38 |
ROIC % (ttm) | -20.16 |
Dividend Yield % | -- |
Altman Z-Score | 2.02 |
TSXV:AVCR Number of Guru Trades
TSXV:AVCR Volume of Guru Trades
Gurus Latest Trades with TSXV:AVCR
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
TSXV:AVCR is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Avricore Health Inc Insider Transactions
No Available Data